ACTRN12610000285055
Not yet recruiting
未知
A 12-week randomised, parallel dietary intervention to compare the effects of consuming 30g or 60g of nuts per day, or no nuts (control) on biomarkers of chronic disease, including blood lipids, inflammation, endothelial function, and body composition in overweight and obese individuals.
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Overweight / Obesity
- Sponsor
- niversity of Otago
- Enrollment
- 90
- Status
- Not yet recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •The inclusion criteria are males and females aged between 18 and 65 years with a Body Mass Index (BMI) greater than or equal to 25 \[weight (kg) / height (m2\)]
Exclusion Criteria
- •The exclusion criteria are smokers. Pregnant or breastfeeding women. People who have asthma. People who are on weight loss programmes. People with food allergies or food aversions to nuts. People who have inflammatory diseases such as Crohn's or Celiac disease. People who have familial or secondary hyperlipidaemia or major chronic diseases such as cancer, heart disease or diabetes. People who are taking medication known to affect inflammatory markers, e.g. aspirin, ibuprofen, naproxen, glucocorticoids, etc.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Improving the adherence to action plans in patients with chronic obstructive pulmonary diseaseChronic Obstructive Pulmonary Disease (COPD)Respiratory - Chronic obstructive pulmonary diseasePublic Health - Health service researchACTRN12612000269831Royal Prince Alfred Hospital90
Active, not recruiting
Phase 2
Study of efficacy and safety of SAF312 eye drops in subjects with post-operative corneal induced chronic pain (CICP)JPRN-jRCT2011220008Yamada Hiroyuki15
Completed
Not Applicable
Psychological treatments of post-traumatic stress disorderPost-traumatic stress disorder (PTSD)Mental and Behavioural DisordersStress disordersISRCTN48524925King's College London (UK)120
Active, not recruiting
Not Applicable
A 12-week treatment, randomized, double-blind, parallel group, multicenter study to evaluate the efficacy of the valsartan/simvastatin combinations 160/20mg up titrated to 320/20mg versus 160/40mg up titrated to 320/40mg in patients with both essential hypertension and hypercholesterolemiaEssential hypertension and hypercholesterolemiaEUCTR2005-002382-36-DEovartis Pharma Services AG796
Active, not recruiting
Not Applicable
A 12-week treatment, randomized, double-blind, parallel group, multicenter study to evaluate the efficacy of the valsartan/simvastatin combinations 160/20mg up titrated to 320/20mg versus 160/40mg up titrated to 320/40mg in patients with both essential hypertension and hypercholesterolemiaEUCTR2005-002382-36-SEovartis Pharma Services AG796